Christopher C. Lemasters - Net Worth and Insider Trading
Christopher C. Lemasters Net Worth
The estimated net worth of Christopher C. Lemasters is at least $0 dollars as of 2024-09-21. Christopher C. Lemasters is the EVP, Chief Business Officer of Mirati Therapeutics Inc and owns about 0 shares of Mirati Therapeutics Inc (MRTX) stock worth over $0. Details can be seen in Christopher C. Lemasters's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher C. Lemasters has not made any transactions after 2019-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher C. Lemasters
Christopher C. Lemasters Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher C. Lemasters owns 1 companies in total, including Mirati Therapeutics Inc (MRTX) .
Click here to see the complete history of Christopher C. Lemasters’s form 4 insider trades.
Insider Ownership Summary of Christopher C. Lemasters
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2019-02-14 | EVP & CHIEF BUSINESS OFFICER |
Christopher C. Lemasters Latest Holdings Summary
Christopher C. Lemasters currently owns a total of 1 stock. Christopher C. Lemasters owns 0 shares of Mirati Therapeutics Inc (MRTX) as of February 14, 2019, with a value of $0.
Latest Holdings of Christopher C. Lemasters
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2019-02-14 | 0 | 58.70 | 0 |
Holding Weightings of Christopher C. Lemasters
Christopher C. Lemasters Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher C. Lemasters has made a total of 0 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years. The most-recent trade in Mirati Therapeutics Inc is the sale of 60,000 shares on February 14, 2019, which brought Christopher C. Lemasters around $4 Million.
Insider Trading History of Christopher C. Lemasters
- 1
Christopher C. Lemasters Trading Performance
Christopher C. Lemasters Ownership Network
Christopher C. Lemasters Owned Company Details
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Christopher C. Lemasters is the EVP & CHIEF BUSINESS OFFICER of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , EVP & Chief Commercial Officer Benjamin Hickey , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Christopher C. Lemasters made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 8,522 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,076 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,509,661 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
Christopher C. Lemasters Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher C. Lemasters. You might contact Christopher C. Lemasters via mailing address: C/o Mirati Therapeutics, Inc., 9393 Towne Centre Drive, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
